Stage IIA Rectal Cancer AJCC v8

Explore clinical trials studying Stage IIA Rectal Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

7 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Stage IIA Rectal Cancer AJCC v8 trial results

Recruiting

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

NCT06780787

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

NCT03594630

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

NCT02107105

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

NCT04703101

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +18 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

NCT05081024

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +17 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

Fred Hutch Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

NCT03516942

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 716 locations

View Trial Details

Active, Not Recruiting

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

NCT04104139

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +15 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Stage IIA Rectal Cancer AJCC v8

Stage IIA Rectal Cancer AJCC v8 trial results

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

Related conditions